Visitor Monitoring Drug History: ZYPREXA
 
Drugs Directory of False Positives DRUGS THAT CAUSES A FALSE POSITIVE ON A DRUG TEST
 
Browse by Letter: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Label and Approval History

Drug Name: ZYPREXA
FDA Application No: (NDA) 020592
Active Ingredient(s): OLANZAPINE
Company: LILLY
 
Label History
 
View the label approved on July 10, 2007 for ZYPREXA, (NDA) 020592


To see older, previously-approved labels, go to the "Approval History" section of this page. Older labels are for historical information only and should not be used for clinical purposes.
 
 
 
Approval History
 
Action DateSupplement NumberSort imageApproval TypeLetters, Reviews, Labels, Patient Package Insert
7/6/2007 043Labeling Revision Letter
Label 
7/6/2007 042Labeling Revision Letter
Label 
11/29/2006 038Labeling Revision Letter
Label 
2/23/2006 035Labeling Revision Letter
Label 
9/13/2005 034Labeling Revision Letter 
2/16/2006 032Labeling Revision Letter
Label 
8/25/2006 029Labeling Revision Letter
Label 
2/16/2006 027Labeling Revision Letter
Label 
8/3/2005 026Labeling Revision Letter 
6/29/2005 020Labeling Revision Letter 
1/14/2004 019New or Modified Indication Letter
Label 
7/10/2003 018New or Modified Indication Letter
Label
Review 
1/22/2002 016Package Change  
3/13/2001 014Control Supplement  
11/9/2000 011New or Modified Indication Review 
1/11/1999 010Labeling Revision  
3/23/1998 007Manufacturing Change or Addition  
3/17/2000 006New or Modified Indication Review 
12/4/1997 005Control Supplement  
9/9/1997 004Manufacturing Change or Addition  
4/18/1997 003Manufacturing Change or Addition  
2/19/1997 001Manufacturing Change or Addition  
9/30/1996 000Approval Patient Information Sheet 
 
Therapeutic Equivalents
©2019 Drugs That Causes a False Positive on a Drug Test